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Over the past few decades, numerous initiatives have sought to
engage members of the public in decisions concerning bioscience
and biotechnologies as early as possible in the development of
scientific research, based on the belief that such participation is in
the public interest. What these initiatives hope to achieve,
however, varies with the motivations for seeking public input. In
some cases, they reflect the belief that citizens who will be affected
by decisions have the right to participate in those decisions,
especially when the research is funded by their tax contributions
(this would be what social scientists term a normative justification).
In other cases, they reflect a desire to reduce conflict, help (re)build
trust, and smooth the way for new innovations (in other words, the
reason is instrumental). And in still others, they reflect the
assumption that such participation from people who will use and/
or be affected by a technology will raise questions about the real-
life functioning of developments when they leave the laboratory,
perhaps leading to innovations that perform better in complex
real-world conditions, or that may be more socially, economically,
and environmentally viable (we could term these ‘‘substantive
justifications’’) [1,2].
Not only do the reasons for soliciting public participation vary,
so do perspectives on who might constitute the appropriate public
in such endeavours. Should initiatives enlist the input of randomly
selected citizens, those with particular interests or kinds of
knowledge, those with (or without) strong prior views, those who
are specially affected groups such as patients or farmers? For
reasons that may be genuine or symbolic, ‘‘public engagement’’
has become almost obligatory in major programmes of publicly
funded research aimed at the development of novel biotechnol-
ogies.
Current proposals for engaging the public—‘‘participatory
Technology Assessment’’ (pTA, as it tends to be termed in
continental Europe) or ‘‘upstream public engagement’’ (as it is
commonly termed in the UK)—are, in many ways, a reaction to
the widely perceived problems with the Ethical, Legal, and Social
Issues (ELSI) approach that was pioneered in the Human Genome
Project. The ELSI approach has been criticized for focusing on the
social implications of technological developments, without encour-
aging serious debate about the nature of the developments
themselves and the priorities they embody. Public engagement
proposals also respond to the widespread perception among
politicians and policy makers that there is a ‘‘crisis of trust’’ in the
relations between science, politics, commerce, and society.
Reflecting this perception, a recent Nature editorial [3] suggested
using ‘‘participatory technology assessment’’ as a way to achieve
improved integration of stakeholder input into decision-making
regarding technological innovations. This editorial was prompted
by a report, published by the Woodrow Wilson International
Center for Scholars in Washington, D.C. [4], that lays out a new
vision for US technology assessment, points to recent international
experience, particularly in Europe, and calls for a broader,
‘‘participatory technology assessment’’ model that supplements
expert opinion with early input from all corners of society.
pTA incorporates several analogous approaches which have
been given different names by their respective authors, including:
constructive technology assessment [5], interactive technology
assessment [6], real-time technology assessment [7], upstream
public engagement [8,9], and technology appraisal [2]. pTA has
been implemented through a range of methods, including
consensus conference, citizens juries, stakeholder workshops,
deliberative polling, and public dialogues. From our perspective,
what is particularly interesting about these initiatives is that they
do not focus on making better predictions of public concerns,
predicting the potential risks and benefits of a new scientific field,
nor do they seek to forestall controversy or to develop ways to
manage downstream problems or external outcomes. Rather, they
seek to enable a range of actors, including lay publics, but also the
widest possible range of people who might be interested or
affected, to help shape the trajectory of innovation and, where
possible, to keep them open to alternative pathways.
In part, this approach is a recognition of Collingridge’s now
famous ‘‘dilemma of control,’’ in which ‘‘the social consequences
of a technology cannot be predicted early in the life of the
technology. By the time undesirable consequences are discovered,
the technology is often so much part of the whole economic and
social fabric that its control is extremely difficult. This is the
dilemma of control. When change is easy, the need for it cannot be
foreseen; when the need for change is apparent, change has
become expensive, difficult and time consuming’’ [10]. Collin-
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gridge argued for the need to develop a ‘‘theory of decision making
under ignorance’’: ‘‘Since the future is extremely uncertain,
options which allow the decision maker to respond to whatever the
future brings are to be favoured.’’ Of course, such flexibility is
difficult to achieve.
Thirty years on, this dilemma, developed in connection to large
scale engineering technologies, has become increasingly relevant
to the biosciences, where uncertainties as well as potential (positive
and negative) stakes for society are particularly high. Political and
scientific institutions, troubled by controversies over emerging
technologies, most notably GM crops and human embryo
research, have developed a new interest in the role that can be
played by social scientists in generating public engagement at an
early stage in scientific and technological development. pTA, and
‘‘upstream engagement’’—in which engagement occurs before an
innovation has become a fait accompli and pathways of
development are still open to debate and scrutiny—have been
one dimension of this.
In Europe, such participatory initiatives have been experiment-
ed with quite extensively since the early 1990s. They have also
been tried to a more limited extent in the US and elsewhere,
including in ‘‘the global South’’—developing and least-developed
nations [11]. In the developed world, such initiatives are
increasingly seen as the solution to the perceived problem of
public mistrust in science and scientists. Yet many scientists still
view them with suspicion and do not accept that members of the
public with no scientific expertise should be involved in decision-
making about scientific matters [12]. Leading scientists are
increasingly ready to acknowledge that the public has the right
to participate in decisions about the applications of science, as
recently argued by Lord Rees, President of the UK’s Royal
Society, Master of Trinity College, and Astronomer Royal [13].
However, this acceptance seldom extends to giving members of
the public a role in decisions about the aims, motives, direction,
funding, and regulation of scientific research, even though
qualitative research on public attitudes by social scientists
systematically identifies these questions as crucial for lay citizens’
appraisal of developments in science and technology (e.g., [14,15]).
We should, of course, welcome the new readiness of research
funders to build ‘‘public attitude’’ research into many of their big
projects at an early stage. Synthetic biology and nanotechnology
are examples of areas in which research institutions and their
funders are seeking to engage the public, stakeholders and social
scientists early on in the development of the field. However, many
who are involved with these initiatives—social scientists, repre-
sentatives of NGOs, members of the public recruited as
participants—are sceptical about the value of these ‘‘public
dialogues.’’ They often merely describe the beliefs and attitudes
of groups comprised of people selected on the basis that they do
not have specialised knowledge or strong opinions about the topic
in question. And the knowledge gained from these initiatives often
seems directed towards anticipating controversy in order to ward it
off, rather than to giving the public any actual role in decisions
about research trajectories. While some scientific researchers may
be wary of involving non-specialists in decisions about the
priorities and direction of research, they also need to acknowledge
that social factors—beliefs, values, assumptions about what kinds
of problems are important to address and what kinds of knowledge
might be desirable or useful—are inescapably part of the
deliberations of those who shape and fund research priorities in
the contemporary world. Genuine and effective public engage-
ment requires us—both life scientists and social scientists—to be
more open, more serious, and more inventive in addressing these
issues.
This series aims to investigate, through specific case studies,
whether, and under what conditions, it is possible to engage the
public in scientific issues in meaningful ways in decision-making
about the innovation pathways of biosciences. We welcome
articles about engagement initiatives that seek to influence the
trajectory of scientific research, and the culture of scientific
institutions. We particularly welcome articles written by or with
scientists who have been involved in such initiatives, describing
examples where the diverse participants involved agree that
positive outcomes were achieved and so might provide models for
further development. In the first article, published today (doi:
10.1371/journal.pbio.1000551), Jean Masson and colleagues
describe their experience using interactive technology assessment
to solicit input from a broad range of stakeholders for a field trial
of genetically modified grapevines in French winegrowing country,
in a context—genetically modified crops and winemaking—where
resistance to innovation runs deep.
As long-time observers of the processes that influence long-term
decisions and institutional structures, we appreciate that retro-
spective analyses of the outcomes of initiatives that occurred some
years ago could be particularly relevant, including those that
reflect back on earlier projects for ‘‘scientific citizenship’’ or ‘‘social
responsibility of scientists.’’ Contributions to the Public Engage-
ment in Science Series are encouraged; ideas should be sent to
Bio_Pub@plos.org.
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